Back
Neurocrine Biosciences Stock Predictions
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pm
Sell
41
NBIX
Neurocrine Biosciences
Last Price:
120.45
Seasonality Move:
9.9%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Neurocrine Biosciences Stock Forecast
- Over the next 52 weeks, Neurocrine Biosciences has on average historically risen by 39.4% based on the past 28 years of stock performance.
- Neurocrine Biosciences has risen higher in 18 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 64.29%
-
Is Neurocrine Biosciences Stock Undervalued?
The current Neurocrine Biosciences [NBIX] share price is $119.85. The Score for NBIX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal. - NBIX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Neurocrine Biosciences Stock Go Up Next Year?
- Over the next 52 weeks, Neurocrine Biosciences has on average historically risen by 39.4% based on the past 28 years of stock performance.
Neurocrine Biosciences Stock Rating
Sell
41
Neurocrine Biosciences (NBIX)
is a Sell
Is Neurocrine Biosciences overpriced?
- Neurocrine Biosciences has risen higher in 18 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 64.29%
Neurocrine Biosciences Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
neurocrine.com
52-Week Data
52-Week High:
157.98
52-Week Low:
103.63
Prediction Charts
Market Cap:
12.1B
Price in USD:
119.85
Volume:
1.05M
Beta:
0.77
Technical Analysis
SMA50:
139.98
SMA100:
138.86
SMA200:
136.32
52-Wk Change:
7.04%
Stock Predictions
-
Is Neurocrine Biosciences stock public?
Yes, Neurocrine Biosciences is a publicly traded company. -
What is the Neurocrine Biosciences stock quote today?
The Neurocrine Biosciences stock price is 119.85 USD today. -
How to buy Neurocrine Biosciences stock online?
You can buy Neurocrine Biosciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Aug-29 | 125.19 | 128.43 | 129.50 | 125.01 |
| Aug-30 | 128.01 | 127.16 | 129.68 | 123.84 |
| Sep-3 | 127.19 | 125.10 | 128.81 | 123.78 |
| Sep-4 | 124.59 | 122.54 | 125.02 | 120.95 |
| Sep-5 | 122.49 | 121.12 | 123.64 | 119.92 |
| Sep-6 | 122.20 | 120.17 | 122.75 | 119.85 |
| Sep-9 | 120.14 | 120.64 | 122.30 | 119.75 |
| Sep-10 | 120.18 | 119.10 | 120.77 | 118.04 |
| Sep-11 | 119.67 | 121.50 | 122.25 | 119.06 |
| Sep-12 | 121.04 | 121.28 | 122.09 | 119.49 |
| Sep-13 | 120.19 | 122.25 | 123.39 | 119.82 |
| Sep-16 | 122.91 | 122.25 | 123.57 | 121.94 |
| Sep-17 | 122.50 | 122.31 | 123.52 | 121.00 |
| Sep-18 | 123.00 | 119.85 | 123.49 | 119.37 |
Neurocrine Biosciences Earnings
Neurocrine Biosciences Earnings Report: Per Share Neurocrine Biosciences Earnings Q1 Q2 Q3 and Q4 last year and next year.
Neurocrine Biosciences Forecast Revenue Growth
Neurocrine Biosciences Stock Analysis: Historical quarterly revenues per share for Neurocrine Biosciences and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.48 per share, an increase next quarter of $0.36 per share, an increase this year of $2.34 per share, and an increase next year of $1.55 per share.
* Neurocrine Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.